文献速递细菌感染、耐药与抗菌药物

评估两种商业肉汤微量稀释系统对达巴万星敏感性检测的性能:针对耐甲氧西林金黄色葡萄球菌及其他耐药革兰阳性球菌

Evaluation of two commercial broth microdilution systems for dalbavancin susceptibility testing of methicillin-resistant Staphylococcus aureus and other resistant Gram-positive cocci.
PubMed 文献 · Clin Microbiol Infect · 2024-03-15

本研究以参考肉汤微量稀释法为对照,评估两种商业肉汤微量稀释系统(Merlin E1-185-100与ThermoFisher FDANDPF)对200株多药耐药革兰阳性球菌临床分离株及2株质控菌株的达巴万星敏感性检测性能,两系统分类一致性与基本一致性均为98%(198/202;95% CI,95.4-99.3%),但均存在对耐达巴万星葡萄球菌的少数假敏感及MIC值低估倾向。

要点

  • 两系统与参考肉汤微量稀释法的分类一致性和基本一致性均为98%(198/202;95% CI,95.4-99.3%)。
  • Merlin系统偏倚值为11%,ThermoFisher系统偏倚值为3%。
  • 两系统对耐达巴万星葡萄球菌均出现少数假敏感,且均存在MIC值低估倾向。

核心结论

  • 两种商业肉汤微量稀释系统与参考肉汤微量稀释法总体相关性良好,但均存在MIC值低估倾向,对耐达巴万星葡萄球菌出现少数假敏感。

研究设计与样本

  • 研究纳入200株非重复多药耐药革兰阳性球菌临床分离株,包括180株耐甲氧西林金黄色葡萄球菌、10株耐万古霉素肠球菌、7株耐利奈唑胺表皮葡萄球菌和3株耐甲氧西林凝固酶阴性葡萄球菌,另加金黄色葡萄球菌ATCC 29213和粪肠球菌ATCC 29212质控菌株。
  • 按ISO 20776-1标准从同一细菌接种物进行检测,并按ISO 20776-2标准比较结果。

主要发现

  • 参考肉汤微量稀释法显示92.6%(187/202)的菌株对达巴万星敏感,少数葡萄球菌和所有产VanA肠球菌显示耐药表型。
  • 与参考方法相比,Merlin和ThermoFisher系统的分类一致性均为98%(198/202;95% CI,95.4-99.3%),基本一致性均为98%(198/202;95% CI,95.4-99.3%)。
  • 两商业系统对耐达巴万星葡萄球菌均观察到少数假敏感。
  • Merlin系统偏倚值为11%,ThermoFisher系统偏倚值为3%。

关键数值与推荐

  • 参考肉汤微量稀释法敏感率为92.6%(187/202)。
  • 两系统分类一致性和基本一致性均为98%(198/202;95% CI,95.4-99.3%)。
  • Merlin系统偏倚值为11%,ThermoFisher系统偏倚值为3%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需纳入更多耐药分离株的进一步研究以更好地评估该问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aims to evaluate two commercial broth microdilution (BMD) systems, E1-185-100 (Merlin) and FDANDPF (ThermoFisher), for dalbavancin susceptibility testing in comparison with reference BMD assay. METHODS: Study collection was composed of 200 non-replicate multidrug-resistant Gram-positive cocci of clinical origin, including 180 methicillin-resistant Staphylococcus aureus, 10 vancomycin-resistant enterococci, seven linezolid-resistant Staphylococcus epidermidis, and three methicillin-resistant coagulase-negative staphylococci. S. aureus ATCC 29213 and Enterococcus faecalis ATCC 29212 reference strains were also included as controls. Testing was performed according to the ISO 20776-1 standard, starting from the same bacterial inoculum, and results were compared according to the ISO 20776-2 standard. RESULTS: Reference BMD showed that 92.6% (187/202) of the strains were susceptible to dalbavancin, whereas few staphylococci and all VanA-producing enterococci showed a resistant phenotype. In comparison with the reference method, Category Agreement and Essential Agreement were 98% (198/202; 95% CI, 95.4-99.3%) and 98% (198/202; 95% CI, 95.4-99.3%) for both Merlin and ThermoFisher panels. A few false susceptibilities were observed, for both commercial systems, with dalbavancin-resistant staphylococci. BIAS values of 11% and 3% were calculated for the Merlin and ThermoFisher systems, respectively. DISCUSSION: This study, reporting the first evaluation of the two commercially available BMD assays for dalbavancin susceptibility testing, revealed an overall good correlation with reference BMD, although with some underestimation tendency of MIC values by both commercial systems. Further studies involving a higher number of resistant isolates will be necessary to better evaluate this issue.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Baccani I, Antonelli A, Cuffari S, et al. Evaluation of two commercial broth microdilution systems for dalbavancin susceptibility testing of methicillin-resistant Staphylococcus aureus and other resistant Gram-positive cocci. Clin Microbiol Infect. 2024. PMID: 38492739. doi:10.1016/j.cmi.2024.03.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。